EP2134354A4 - Composition and method for treating papilloma virus and equine sarcoids - Google Patents

Composition and method for treating papilloma virus and equine sarcoids

Info

Publication number
EP2134354A4
EP2134354A4 EP08731068A EP08731068A EP2134354A4 EP 2134354 A4 EP2134354 A4 EP 2134354A4 EP 08731068 A EP08731068 A EP 08731068A EP 08731068 A EP08731068 A EP 08731068A EP 2134354 A4 EP2134354 A4 EP 2134354A4
Authority
EP
European Patent Office
Prior art keywords
composition
papilloma virus
sarcoids
equine
treating papilloma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08731068A
Other languages
German (de)
French (fr)
Other versions
EP2134354A2 (en
Inventor
Stefano Ferrari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAINT SIMEON Lda
Original Assignee
SAINT SIMEON Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAINT SIMEON Lda filed Critical SAINT SIMEON Lda
Publication of EP2134354A2 publication Critical patent/EP2134354A2/en
Publication of EP2134354A4 publication Critical patent/EP2134354A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
EP08731068A 2007-03-02 2008-02-29 Composition and method for treating papilloma virus and equine sarcoids Withdrawn EP2134354A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89257307P 2007-03-02 2007-03-02
PCT/US2008/055425 WO2008109401A2 (en) 2007-03-02 2008-02-29 Composition and method for treating papilloma virus and equine sarcoids

Publications (2)

Publication Number Publication Date
EP2134354A2 EP2134354A2 (en) 2009-12-23
EP2134354A4 true EP2134354A4 (en) 2012-03-21

Family

ID=39733193

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08731068A Withdrawn EP2134354A4 (en) 2007-03-02 2008-02-29 Composition and method for treating papilloma virus and equine sarcoids

Country Status (5)

Country Link
US (2) US7846430B2 (en)
EP (1) EP2134354A4 (en)
CA (1) CA2679939A1 (en)
RU (1) RU2009136424A (en)
WO (1) WO2008109401A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895610B1 (en) 2007-05-18 2014-11-25 Heldi Kay Platinum (IV) compounds targeting zinc finger domains
CN111643655A (en) * 2013-12-18 2020-09-11 帝斯曼知识产权资产管理有限公司 Composition comprising lysozyme hydrolysate for keratin-containing tissues
US10668161B2 (en) * 2014-02-24 2020-06-02 The Regents Of The University Of California Therapeutic hyperbranched polyglycerol encapsulated biomolecules
CN112175090A (en) * 2019-07-03 2021-01-05 深圳市雅臣智能生物工程有限公司 Human lysozyme conjugate and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021463A2 (en) * 1995-01-13 1996-07-18 Nika Health Products Limited New applications of lysozyme dimer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW205070B (en) * 1986-06-30 1993-05-01 Takeda Pharm Industry Co Ltd
US5200182A (en) * 1988-05-26 1993-04-06 Nika Health Products, Ltd. Antiviral or antibacterial composition and method of use
IT1229192B (en) * 1989-02-27 1991-07-25 Prodotti Antibiotici Spa PROCEDURE FOR THE BACTERIAL DECONTAMINATION OF FOODS OF VEGETABLE ORIGIN.
US6147086A (en) * 1999-09-01 2000-11-14 Brenman; Steven A. Method employing imiquimod cream for treatment of topical sarcoidosis on equine
JP2004505616A (en) * 2000-07-07 2004-02-26 ニューヨーク　ユニバーシティ Anti-HIV peptides, anti-tumor peptides, and fragments of lysozyme
US8088928B2 (en) * 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021463A2 (en) * 1995-01-13 1996-07-18 Nika Health Products Limited New applications of lysozyme dimer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ALTAMAR-RÍOS J: "[Lysozyme in the treatment of juvenile laryngeal papillomatosis. A new concept in its etiopathogenesis].", ANALES OTORRINOLARINGOLÓGICOS IBERO-AMERICANOS 1990 LNKD- PUBMED:2288400, vol. 17, no. 5, 1990, pages 495 - 504, XP009155097, ISSN: 0303-8874 *
ANN-KRISTIN MOSSBERG ET AL: "Structure and function of human [alpha]-lactalbumin made lethal to tumor cells (HAMLET)-type complexes", FEBS JOURNAL, vol. 277, no. 22, 1 November 2010 (2010-11-01), pages 4614 - 4625, XP055015362, ISSN: 1742-464X, DOI: 10.1111/j.1742-4658.2010.07890.x *
GUSTAFSSON L ET AL: "TREATMENT OF SKIN PAPILLOMAS WITH TROPICAL ALPHA-LACTALBUMIN-OLEIC ACID", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 350, no. 26, 24 June 2004 (2004-06-24), pages 2663 - 2672, XP008052523, ISSN: 1533-4406, DOI: 10.1056/NEJMOA032454 *
KOPCZEWSKI ANTONI ET AL: "Usefulness of Lydium-KLP in treatment of some tumors in dogs and cats", MEDYCYNA WETERYNARYJNA, vol. 56, no. 3, March 2000 (2000-03-01), pages 168 - 171, XP009155104, ISSN: 0025-8628 *
KRISTINA WILHELM ET AL: "Protein oligomerization induced by oleic acid at the solid-liquid interface - equine lysozyme cytotoxic complexes", FEBS JOURNAL, vol. 276, no. 15, 1 August 2009 (2009-08-01), pages 3975 - 3989, XP055015369, ISSN: 1742-464X, DOI: 10.1111/j.1742-4658.2009.07107.x *
MORAND ET AL: "Effects of dimerized lysozyme (KLP-602) on the cellular and humoral defence mechanisms in sheatfish (Silurus glanis): in vitro and in vivo study.", VETERINARY RESEARCH, vol. 30, no. 4, 1 January 1999 (1999-01-01), pages 411 - 418, XP055015393, ISSN: 0928-4249 *

Also Published As

Publication number Publication date
US7846430B2 (en) 2010-12-07
RU2009136424A (en) 2011-04-10
US20080213242A1 (en) 2008-09-04
EP2134354A2 (en) 2009-12-23
US9149514B2 (en) 2015-10-06
WO2008109401A2 (en) 2008-09-12
CA2679939A1 (en) 2008-09-12
WO2008109401A3 (en) 2008-12-11
US20110027255A1 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
HK1250936A1 (en) Compositions and methods for treating viral infections
HRP20190214T1 (en) Compositions and methods for treating purpura
IL248652A0 (en) Methods, compositions and apparatuses for facilitating regeneration
PL2578081T3 (en) Compositions, methods, and devices for treating liver disease
ZA201006586B (en) Plant disease controlling composition and method for controlling plant disease
EP2125618A4 (en) Particle removal method and composition
EP2344155A4 (en) Composition and method for treating dry eye syndrome
EP2229175A4 (en) Composition and method for dermal regeneration
IL210097A0 (en) Compositions and methods for treating unfluenza
HUP0700369D0 (en) Pharmaceutical compositions and method for treating schizofrenia
EP2144712A4 (en) Apparatus and method for treating materials with compositions
IL206000A0 (en) Pharmaceutical compositions for treating depression and anxiety
EP2114457A4 (en) Composition for promoting bone regeneration and restoration
GB2469220B (en) Pharmaceutical composition for treating diabetes and preparation method thereof
EP2120994A4 (en) Methods and compositions for treating hypoglycemic disorders
HK1129596A1 (en) Methods and compositions for treating disease
EP2134354A4 (en) Composition and method for treating papilloma virus and equine sarcoids
IL185555A0 (en) Method and composition for treating diabetes
GB0620930D0 (en) Composition and method for use thereof
ZA201103455B (en) Composition and method for controlling pests
ZA201004212B (en) Method and composition for treating an alpha adrenoceptor-mediated condition
IL200887A0 (en) Compositions and method for treating pediatric hypogonadism
EP2170314A4 (en) Methods and compositions for treating phenylketonuria
GB0507963D0 (en) Composition and method for treating disease
GB0522732D0 (en) Composition and method for treating disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091002

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20120222

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/46 20060101AFI20120216BHEP

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140121

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150901